TP53 and urinary bladder cancer: Seven of 28 participants with a P/LP variant in other CSGs had a past history of non-RCC cancer (bladder cancer, prostate cancer, testicular cancer and breast cancer), including a case with a germline TP53 mutation with synchronous uterine cancer, central nervous system cancer and chRCC at 45 years.